Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Lapatinib (250 mg) Tablet
Therapeutic Category
Oncology, Anticancer
Dosage Form
Tablet
Packaging Type
in a Bottle
Packaging
30 Tablets
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
LAPANIB 250 Tablet (Lapatinib 250 mg) is a highly specialized, oral, targeted cancer medicine classified as a Dual Tyrosine Kinase Inhibitor (TKI). It is a critical treatment component for patients diagnosed with HER2-positive advanced or metastatic breast cancer.
Mechanism and Impact:Lapatinib works by selectively and reversibly binding to the intracellular domain of two key receptors: Human Epidermal Growth Factor Receptor 2 (HER2) and Epidermal Growth Factor Receptor (EGFR). By competitively blocking the signaling pathways, Lapatinib effectively halts the uncontrolled tumor cell growth. This dual-action mechanism is particularly valuable in treating cancers that have progressed following treatment with other HER2-targeted agents.
Key Therapeutic Uses (Combination Therapy):
With Capecitabine: For patients whose cancer has progressed after prior therapy including an anthracycline, a taxane, and trastuzumab.
With Letrozole: For postmenopausal women with hormone receptor-positive and HER2-positive metastatic breast cancer.
We offer an exclusive PCD Pharma Franchise opportunity for LAPANIB 250, providing partners with monopoly rights in this specialized, high-demand segment of targeted breast cancer therapeutics.
Common side effects include nausea, dizziness, stomach discomfort, muscle pain, headache, and an increased risk of bleeding or bruising.
Rosutyle Gold 20/150 Tablet is prescribed for individuals at high risk of cardiovascular diseases, including heart attack, stroke, and atherosclerosis, especially those with high cholesterol and hypertension.
Use only under medical supervision. Regular monitoring of cholesterol levels, liver function, and bleeding risk is recommended.
Store at room temperature (15-30°C) in a dry place away from direct sunlight and moisture. Keep out of reach of children.
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Prazosin (5 mg) Sustained Release
Composition : Metoprolol Succinate 100mg PR Tablet
Composition : Metoprolol 12.5 XL Tablet
Composition : Metoprolol Succinate (25mg) ER Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Lapatinib 250mg Tablet has demand in the oncology and specialty medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer care, hospital supply, and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from demand for targeted cancer therapy under oncologist supervision. Lapatinib is a targeted anti-cancer medication that inhibits specific growth factor receptors involved in tumor growth Commonly used in the treatment of HER2-positive breast cancer as prescribed by oncology specialists Supports advanced cancer treatment protocols in specialized healthcare settings This strengthens a high-value oncology and specialty-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Lapatinib 250mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from oncologist prescriptions, hospital and specialty clinic demand, long-term treatment requirements, reliable supply chain support, and good margins in oncology medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.